Exagen：即將迎來轉折點的小型診斷公司 (NASDAQ:XGN)
· seekingalpha.com
Exagen (XGN) 買進建議：營收加速成長、平均銷售價格 (ASP) 改善，以及 2027 年達成損益平衡的明確路徑。
Exagen (NASDAQ: XGN ) is becoming a very interesting diagnostics company as revenue growth accelerates, average selling prices are improving, and management mov...